Case report shows effective use of subcutaneous omeprazole for gastrointestinal symptoms in end-of-life patients, suggesting individualized care approaches.
This case illustrates the safe and effective use of subcutaneous omeprazole for managing upper gastrointestinal symptoms at the end of life in a community setting. It supports the role of flexible prescribing and individualised care to respect patient preferences. Due the unpredictable physiology of people at the end-of-life and the challenges in palliative care research, case reports and expert opinion remain vital evidence for clinical practice.
No takes yet. Share an insight, caveat, or question.
Landers et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: